Neonatal Pharmacy Resident/Fellow Research Grant

Supported by Lundbeck, Inc.

Application Deadline: September 15 each year.

 

Pediatric Pharmacy Advocacy Group is an international, nonprofit, professional association representing the interests of pediatric pharmacists and their patients. We are dedicated to improving medication therapy in children. Our sole purpose is to promote safe and effective medication use in children through communication, education, and research.

 

Purpose

 

The Neonatal Pharmacy Resident/Fellow Research Grant supports research in neonatal medication use conducted by pharmacy residents (e.g., PGY-1, PGY-2 pediatric pharmacy resident) and fellows. The primary purpose of the research award is to improve safe and effective use of medications in neonates. Research projects can comprise a wide range of medication-use topics, including but not limited to: technology, safety, and/or pharmacotherapy. A secondary goal of the program is to develop and strengthen the skills of pharmacy residents and fellows by fostering development of mentoring relationships with more experienced senior investigators.

 

Eligibility Criteria

 

The proposed research must involve health services research in neonatal medication use that is conducted by a pharmacy resident (e.g., PGY-1, PGY-2 pediatric pharmacy resident) or fellow. The principal investigator must be a pharmacy resident or fellow and a licensed pharmacist in the country in which they practice. A mentor/advisor must participate in the research project and will be designated as a co-investigator. Both the principal investigator and the mentor/advisor must be members of PPAG. In the application process and grant progress reports, evidence must be included regarding the support and involvement of the mentor/advisor. The proposed study must be approved by an institutional review board (IRB) at the institution at which the research will occur. Evidence of IRB submission must be provided to PPAG with the submitted proposal. Grant funds will not be disbursed until evidence of IRB approval has been received. Multidisciplinary research teams are strongly encouraged. The grant recipients agree to present their results at a PPAG conference (encore presentation is acceptable) and publish the results of their research in a peer-reviewed scientific journal. Publication in the Journal of Pediatric Pharmacology and Therapeutics is encouraged.

 

Funding Information

 

Up to three grants (up to $2,000 each) may be awarded yearly. Grants are awarded to pharmacy residents and/or fellows to provide funding for specific neonatal research related to medication use and are not intended for long-term support of research programs.

 

Funds may be applied to:

Funds may not be applied to:

Application Process

Proposal Review
Grants will be awarded based on merits of the proposal as listed below:

A review committee will consist of members from the PPAG Research Committee and the Neonatal Special Interest Group. The review committee will receive and review proposals and determine awardees.

 

Proposal Deadline

Proposals must be received by PPAG by September 15th. Grant awardees will be informed by October 1st of each year.

 

Past Recipients

 

2009	Keliana O'Mara, PharmD Neonatal Pharmacology Fellow, Women's Hospital of Greensboro, NC
	Emma Tillman, PharmD Fellow, The University of Tennessee Health Science Center, Memphis, TN
2010	Liana Mark, PharmD PGY1 Pharmacy Practice Resident, The Johns Hopkins Hospital, Baltimore, MD
	Emma Tillman, PharmD Fellow, The University of Tennessee Health Science Center, Memphis, TN
2011	Oscar Rafael Herrera, PharmD Fellow, The University of Tennessee Health Science Center, Memphis, TN